trial · primary record
Budesonide delayed release tablet
IgA Nephropathy
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2026-12 |
| Primary endpoint | Cmax |
| Registry ID | NCT07897240 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.602Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897240
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.